CHLSN and colorectal carcinoma: Using human colorectal carcinoma cells that stably expressed cholesin, the group also observed that cholesin was secreted to the medium proportional to varying doses of administered cholesterol, and this process was impaired with NPC1L1 knockdown, the intestinal cholesterol transporter.